Literature DB >> 324726

[Chemotherapy of malignant bone tumors].

K Höffken, S Seeber, W M Gallmeier, U Bruntsch, D K Hossfeld, C G Schmidt.   

Abstract

In several primary malignant tumors significant improvement of formely bad prognosis has been achieved by the introduction of new cytostatic compounds and the study of new cytostatic combination regimens. Adjuvant chemotherapy in osteosarcoma and Ewing's sarcoma led to remarkable increase in survival rates. Leaning on natural history and on remission rates reached by cytostatic treatment in metastasizing stages of disease, proposals for adjuvant chemotherapy are made and chemotherapy regimen appliable on out-patient basis is described.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324726

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

1.  [Multifocal angiosarcoma of the vertebrae and the sternum with visceral metastases (author's transl)].

Authors:  E A Konrad; P Meister
Journal:  Arch Orthop Trauma Surg       Date:  1979-03-19

2.  [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].

Authors:  H Sauer; W Wilmanns
Journal:  Blut       Date:  1978-06-20

3.  [Malignant giant cell tumor of the femur with sarcomatous changes (author's transl)].

Authors:  P Meister; E Konrad; S Stotz
Journal:  Arch Orthop Trauma Surg       Date:  1978-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.